Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Post Views: 191 Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022. A pre-recorded presentation will be available beginning Monday, January 10…